Cowen And Company, LLC Cyma Bay Therapeutics, Inc. Transaction History

Cowen And Company, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.77 - $3.64 $181,712 - $238,784	-65,600 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.23 - $4.6 $20,026 - $28,519	-6,200 Reduced 8.64%	65,600 $222,000
Q3 2021 Nov 12, 2021	BUY	$3.47 - $4.42 $247,331 - $315,044	71,277 Added 13628.49%	71,800 $262,000
Q2 2021 Aug 13, 2021	BUY	$3.94 - $4.92 $2,060 - $2,573	523 New	523 $2,000
Q3 2020 Nov 03, 2020	SELL	$3.32 - $7.24 $82,183 - $179,218	-24,754 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.41 - $4.25 $34,903 - $105,204	24,754 New	24,754 $86,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.